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It is not atypical for patients with posttraumatic stress disor-der (PTSD) to present with several concomitant physical
and mental health problems. These most often include in-
creased reporting of physical symptoms and physical health
problems, increased alcohol consumption, and depressed
mood (1,2). Recent evidence suggests that pain is one of the
most commonly reported symptoms of patients with PTSD,
regardless of the nature of their traumatic experience (for ex-
ample, military combat, motor vehicle accident, or sexual as-
sault). Similarly, patients who have persistent, chronic pain
associated with musculoskeletal injury, serious burn injuries,
and other pathologies (such as fibromyalgia, cancer, or AIDS)
frequently present with symptoms of PTSD. In the past dec-
ade, investigation into the relation(s) between PTSD and the
experience of pain has flourished. To a lesser degree, re-
searchers have developed models that attempt to explain how
the conditions may be linked (3).
This paper has several purposes. First, we provide summary
definitions of the conditions under discussion. Second, we
highlight symptoms from each condition that have similar
characteristics. Third, we summarize the literature on preva-
lence rates of pain experiences in PTSD populations, and vice
versa. Fourth, we articulate potential explanations for the ob-
served association between pain and PTSD. Finally, we dis-
cuss future directions for empirical investigation and clinical
practice that stem from this line of inquiry.
Clinical Implications
 Clinicians treating patients with posttraumatic stress disorder (PTSD) need to pay careful attention to co-occurring
symptoms of pain.
 Likewise, those treating patients with chronic pain need to be aware of the potential influence of PTSD symptoms
on clinical presentation.
 Use of propranolol may be effective in simultaneous relief of co-occurring PTSD and pain symptoms.
Limitation
 The positions suggested in this review warrant careful empirical scrutiny.
It is common for individuals with symptoms of posttraumatic stress disorder (PTSD) to present with co-
occurring pain problems, and vice versa. However, the relation between these conditions often goes unrecog-
nized in clinical settings. In this paper, we describe potential relations between PTSD and chronic pain and
their implications for assessment and treatment. To accomplish this, we discuss phenomenological similarities
of these conditions, the prevalence of chronic pain in patients with PTSD, and the prevalence of PTSD in pa-
tients with chronic pain. We also present several possible explanations for the co-occurrence of these disorders,
based primarily on the notions of shared vulnerability and mutual maintenance. The paper concludes with an
overview of future research directions, as well as practical recommendations for assessing and treating patients
who present with co-occurring PTSD or chronic pain symptoms.
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Definitions
PTSD typically develops following exposure to a situation or
event that is, or is perceived to be, threatening to the well-
being of oneself or another person. As presented in the DSM-
IV-TR (4), symptoms are grouped into 3 clusters: reexperi-
encing of the event (for example, intrusive thoughts and night-
mares), avoidance and emotional numbing (for example,
restricted affect), and hyperarousal (for example, sleep diffi-
culties and hypervigilance). To satisfy criteria for a diagnosis
of PTSD, a person must be exposed to a traumatic event with
actual or perceived threat. In addition, the individual must ex-
perience intense fear or helplessness; must have at least 1 re-
experiencing symptom, at least 3 avoidance and numbing
symptoms, and at least 2 hyperarousal symptoms; must be
bothered by these symptoms for more than 1 month; and must
be significantly distressed or impaired in social, occupational,
or other functioning. Recent findings indicate that prevalence
rates for PTSD in the general population range between 7%
and 12% (5); in certain at-risk groups (for example, survivors
of sexual assault, motor vehicle accidents, or military com-
bat), the rates can be substantially higher (4).
Accumulating evidence from factor analytic investigations
(6–9) suggests that the PTSD symptom clusters outlined in the
DSM-IV-TR diagnostic criteria may not best conceptualize
PTSD symptom profiles. While the optimal symptom cluster
arrangement differs slightly among each of these investiga-
tions, a consistent finding is that the 2 elements of the current
avoidance and numbing cluster should be considered inde-
pendently. In short, the empirical evidence suggests that
PTSD comprises 4 distinct symptom clusters: reexperiencing,
avoidance, numbing, and hyperarousal. Recent treatment
studies show that it is important to distinguish among the 4
clusters because important effects of intervention—particu-
larly in the avoidance and numbing domains—are lost if the 4
clusters are not examined separately (10,11). This has not be-
come clinical convention, but as will become evident below, it
is an increasingly common consideration in empirical work.
The traditional medical model conceptualizes pain as a pure
sensory experience arising from noxious stimulation (for ex-
ample, organic pathology and physical injury). Contemporary
models now recognize that biological, psychological (for ex-
ample, cognitive, affective, and behavioural), and social fac-
tors are involved in the experience (12,13). These
contemporary models conceptualize pain as a complex, sub-
jective, perceptual phenomenon involving numerous dimen-
sions (for example, intensity, quality, time course, and
personal meaning). Pain is typically acute and occurrs in re-
sponse to actual or potential tissue damage to motivate adap-
tive processes that facilitate escape and promote recuperative
behaviour (14). However, for about 30% of adults in devel-
oped countries, the experience of pain persists over long
periods of time, whether it is related to injury or to some or-
ganic pathology (15); it often leads to distress, suffering, and
functional disability (16,17); and it is associated with inappro-
priate use of medical services, costly insurance claims, and
work absenteeism (18,19). When pain persists for at least 3
months, it is considered chronic (20). Many, but not all, pa-
tients with chronic pain exhibit considerable anxiety, avoid-
ance behaviour, and general emotional lability, as well as
attentional biases and hypervigilance for pain cues (21). In
Canada, chronic musculoskeletal pain is the second most
common chronic health condition, costing the health care sys-
tem approximately $18 billion annually.
Symptom Overlap
A close look at the definitions provided above indicates that
there is some degree of symptom overlap between PTSD and
chronic pain. In particular, anxiety and hyperarousal, avoid-
ance behaviour, emotional lability, and elevated somatic fo-
cus are frequently observed in both conditions. Both PTSD
and chronic pain are characterized by hypervigilance (21,22)
and attentional bias (23,24) for stimuli that are specific to each
condition. There are also data suggesting that startle responses
are intensified during states of negative affect (25), to which
both conditions can be a major contributor (26). Further, pre-
liminary data suggest that stress responses and pain modula-
tion are dysregulated in both conditions (27,28). Collectively,
these findings indicate that PTSD and chronic pain share simi-
lar response patterns in the cognitive, behavioural, and
physiological domains; in the opinion of some (3,29), the data
suggest an intricate connection between the 2 conditions.
Prevalence Estimates
One method for gaining preliminary insight into the rela-
tion(s) between PTSD and pain—albeit a limited one in that it
does not allow for conclusions regarding the nature of the as-
sociation (see below)—is to assess the degree to which they
co-occur. As might be anticipated, based on the preceding dis-
cussion, the literature indicates a high degree of co-
occurrence, regardless of whether pain is being assessed in pa-
tients with PTSD, or vice versa.
Pain in Patients With PTSD
PTSD and PTSD symptoms are associated with greater re-
porting of physical health problems and symptoms (30–34).
They are also strongly associated with current pain, overall
pain ratings, and pain-related disability (29,35); with func-
tional impairment (31,32); and with increased health care
utilization (36). For military veterans, these findings appear to
hold regardless of the theatre (for example, Vietnam or the
Persian Gulf) or the nature of the trauma experienced. At the
acute level, then, there is evidence suggesting that PTSD
symptoms and pain—as well as functional impairments that
might be attributed to either or both—frequently co-occur.
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Does this association hold in cases wherein pain persists be-
yond the acute phase?
In one of the first studies to assess co-occurrence of PTSD and
chronic pain, White and others reported that approximately 1
in 5 military veterans with PTSD developed chronic pain (37).
More striking, Beckham and others observed that the symp-
toms reported by 80% of consecutive outpatient military com-
bat veterans sampled (103/129) satisfied the criteria for
current chronic pain in 1 or more sites, including the back in
77% of cases (29). McFarlane and others found that almost
one-half of a sample of volunteer firefighters with PTSD re-
ported significant musculoskeletal pain, primarily in the back,
compared with 21% of those without PTSD (38). Others
(39,40) have noted that between 20% and 30% of individuals
from community and mental health outpatient samples with
current PTSD report persistent pain symptoms. In a recent
large-scale study of community outpatients, PTSD was asso-
ciated with an increasing number of pain reports over time and
an increased risk of somatic symptoms, even after the re-
searchers controlled for comorbid disorders (41).
PTSD in Patients With Chronic Pain
A growing number of studies have shown that PTSD symp-
toms tend to be elevated in, and to impact on, patients with
chronic pain and fibromyalgia (33,39,42–46). Indeed, it ap-
pears that between 10% and 50% of patients receiving tertiary
care treatment for chronic pain and related conditions have
symptoms that satisfy diagnostic criteria for PTSD, compared
with approximately 8% of the general population. Benedikt
and Kolb, for example, have reported that 10% of a sample of
military veterans being treated for chronic pain also satisfied
diagnostic criteria for PTSD (47). In a study of patients with
chronic musculoskeletal pain associated with work-related in-
jury, we found that 34.7% had symptoms consistent with a di-
agnosis of PTSD (42). We also noted that a significant number
of patients (18.2%) who did not present with full PTSD had
symptoms sufficient for clinical attention; that is, they met the
criteria for 2 of the 3 PTSD symptom clusters. Even more
striking are the various reports from the motor-vehicle acci-
dent literature: these indicate that upward of 50% of patients
receiving treatment for chronic pain present with co-
occurring PTSD (48,49). All these findings are supported by
recent data from the National Comorbidity Study indicating
that patients with musculoskeletal pain are 4 times more likely
to develop PTSD than are those without musculoskeletal pain
(50).
It is, however, important in this context to consider the possi-
bility that the observed rates of PTSD may depend partly on
the heterogeneous ways in which patients with chronic pain
respond to their symptoms and general situation. This hetero-
geneity can be operationalized using the Multidimensional
Pain Inventory (MPI) (51) and an associated empirical clus-
tering procedure called the Multiaxial Assessment of Pain
(MAP) (52,53). These tools identify 3 primary subgroups of
patients with chronic pain, including 1) those who are adap-
tive copers (displaying lower pain severity, pain interference,
and affective distress), 2) those who are interpersonally
distressed (displaying lower perceived social support), and 3)
those who are considered dysfunctional (displaying higher
pain severity, pain interference, elevated affective distress
and fear, and lower activity). As anticipated, we found evi-
dence to support the hypothesis that PTSD is most prevalent in
patients with chronic musculoskeletal pain who are classified
as dysfunctional, compared with interpersonally distressed or
adaptive copers (54). Indeed, we observed that approximately
70% of dysfunctional copers satisfy diagnostic criteria for
PTSD, compared with 21% of interpersonally distressed and
35% of adaptive copers. Others have recently reported similar
findings (unpublished data).
Potential Mechanisms
The foregoing review indicates that pain symptoms and
chronic pain are prevalent in patients with PTSD and that
PTSD symptoms are common in patients with chronic pain,
particularly in those with higher pain severity, more interfer-
ence in daily living, and higher negative affect. However, es-
tablishing co-occurrence provides neither an understanding of
the nature of the relation(s) between the conditions nor an un-
derstanding of the mechanisms by which they are linked. In-
deed, the data reviewed thus far indicate several possible
relation scenarios. For any 2 variables (or conditions), possi-
ble relations are as follows: 1) they co-occur but are unrelated,
2) one causes the other (that is, PTSD causes pain, or vice
versa), 3) each influences the other in some way (for example,
chronic pain exacerbates symptoms of PTSD, or vice versa),
or 4) some third factor (for example, a genetic predisposition)
causes both. It should be noted that the third and fourth possi-
bilities are not mutually exclusive. In most cases, the mount-
ing evidence reviewed below does not strongly support the
first 2 possibilities. It does, however, suggest several mecha-
nisms through which PTSD and chronic pain are closely
linked and influence each other. These mechanisms include
shared vulnerability and mutual maintenance.
Shared Vulnerability
Since PTSD and chronic pain frequently co-occur, it seems
plausible that there may be individual difference factors pre-
disposing people to develop one or both of these conditions.
Consequently, clinical investigators have been working to
identify potential predisposing factors. While several con-
structs hold promise, including the constructs of trait negative
affectivity and harm avoidance, it is anxiety sensitivity that
has been proving most fruitful as a predisposing factor. Anxi-
ety sensitivity denotes a dispositional tendency to become
fearful and, more specifically, refers to the fear of anxiety
symptoms based on the belief that they may have harmful con-
sequences (55,56). For example, a person who has high levels
of anxiety sensitivity is likely to become fearful in response to
chest tightness and shortness of breath, thinking that these
symptoms may signal an impending heart attack. Conversely,
a person with low levels of anxiety sensitivity would likely
find these symptoms to be nothing more than unpleasant. Re-
search suggests that there are 3 basic dimensions of anxiety
sensitivity: fear of publicly observable anxiety reactions, fear
of cognitive dyscontrol, and fear of somatic sensations (56).
Anxiety sensitivity has been shown to be elevated in patients
with PTSD (10,57,58) and in some (59), but not all (60,61),
samples of patients with chronic pain. Patients with persistent
headache pain and those with musculoskeletal pain who are
classified as dysfunctional tend to have elevated anxiety sen-
sitivity relative to other patients with pain (for a review, see
54). These are the same patients with pain who are more likely
to have PTSD (26,54). It has also been shown that the severity
of anxiety sensitivity is positively correlated with severity of
PTSD symptoms (62). Based on these data, it seems plausible
that the anxiety sensitivity construct represents the bridge, or
shared vulnerability, between PTSD and chronic pain.
Evidence suggests that anxiety sensitivity amplifies the inten-
sity of emotional reaction, particularly of fear and anxiety, and
that it is a predisposing factor in panic attacks (56,63). It has
been suggested that elevated anxiety sensitivity may be a pre-
disposing factor both for PTSD (58) and for much of the suf-
fering and disability associated with chronic musculoskeletal
pain (26,64). That is, the tendency to respond with fear to
symptoms of anxiety is thought to predate the development of
PTSD and chronic pain. When people with high anxiety sensi-
tivity levels encounter a traumatic stressor, painful physical
injury, or both, they are believed to respond with a more in-
tense emotional reaction than do those with lower levels. In
the case of PTSD, the degree of alarm caused by the stressor it-
self combined with alarm related to the anxiety sensations
arising from the stressor amplifies the emotional reaction and
thereby increases the risk of developing PTSD (58). In the
case of chronic pain, it also appears that anxiety sensitivity
amplifies fear, anxiety, and associated avoidance responses
when pain-related experiences occur, thereby increasing the
likelihood that pain will be maintained over time (21,64–66).
When the traumatic stressor and pain-precipitating event are
the same or occur in close temporal proximity, anxiety sensi-
tivity may amplify the collective response and may increase
vulnerability for development of both conditions.
Growing evidence suggests that there may be a genetic basis
for this shared vulnerability. Indeed, data indicate that genetic
factors play a role in anxiety sensitivity (67,68), PTSD (69),
and pain (70,71). It may be that there are genetic factors com-
mon to all 3 conditions. Genetically based dysregulations in
serotinergic or GABA-ergic systems may be involved. Con-
sistent with this, dysregulations in both systems have been im-
plicated in pain and in anxiety disorders (71–73).
Mutual Maintenance
Sharp and Harvey have recently proposed a mutual mainte-
nance model to explain the association between PTSD and
chronic pain (3). In essence, they posit that certain compo-
nents of chronic pain (cognitive, affective, and behavioural)
maintain or exacerbate symptoms associated with PTSD and,
likewise, that components of PTSD (physiological, affective,
and behavioural) maintain or exacerbate symptoms associ-
ated with chronic pain. To illustrate: the model holds that
chronic pain serves as a persistent reminder of the trauma and,
conversely, that arousal triggered by the reminder promotes
avoidance of pain-related situations. Distress and disability
appear to have a unidirectional influence on both PTSD and
chronic pain and themselves appear to be influenced directly
by the following 7 proposed mechanisms through which mu-
tual maintenance occurs: 1) attentional and reasoning biases,
2) anxiety sensitivity, 3) reminders of the trauma, 4) avoid-
ance, 5) depression and reduced activity levels, 6) anxiety and
pain perception, and 7) cognitive demand from symptoms that
limits the use of adaptive strategies.
The model and its derivative postulates provide several useful
directions for empirical inquiry, some of which we discuss in
greater detail below. As well, there are several useful clinical
implications. Sharp and Harvey suggest that “reduction in
cognitive and behavioural avoidance (via in vivo and imaginal
exposure) and aiming to increase activity levels (acting as an
exposure intervention) are crucial” (3, p 872) and that there
should be an emphasis on “helping the patient to see links be-
tween their chronic pain problem and PTSD” (3, p 872). (We
also discuss general practice guidelines in greater detail be-
low.) There are, however, some noteworthy conceptual limi-
tations to the proposed model. First, and perhaps foremost,
Sharp and Harvey seem to confuse the issues of shared vulner-
ability and mutual maintenance. It is plausible that anxiety
sensitivity may become elevated through associative learning
(58,74), and thereby serve as a maintaining factor, as opposed
to a preexisting vulnerability factor. However, we feel that
progress in the field will be best facilitated by distinguishing
between the shared vulnerability and mutual maintenance
constructs. Further, Sharp and Harvey provide a somewhat
simplified view of the potentially complex relation (3). In-
deed, given that both PTSD and pain are multidimensional
constructs (for example, both comprise multiple symptom
clusters involving cognition, behaviour, and physiology), it is
plausible that specific sets of symptoms are causally associ-
ated, whereas others are not. Evidence from the clinical set-
ting suggests that subsyndromal presentations of PTSD and
their association with pain may also warrant careful consid-
eration in this regard (75). Finally, while the model recognizes
the importance of feedback loops, there are occasions in
which this feedback is more likely bidirectional than unidirec-
tional. Again, progress in the field will be best facilitated by a
fully articulated model.
Outstanding Issues and Future Directions
One line of research that would assist in disentangling the re-
lation between PTSD and chronic pain involves investigating
the temporal association between these disorders. To the best
of our knowledge, there has been little attention to this issue in
the empirical literature. However, since temporal association
might hold important implications for the manner in which the
disorders are mechanistically linked, progress in the field will
likely require careful consideration of this issue. For any
given patient, researchers (and clinicians) need to determine
whether PTSD or pain came first and the extent to which they
are related. In some cases, it may be that the traumatic event
that led to PTSD involved a physically painful injury or expe-
rience (for example, regaining consciousness during surgery).
In such cases, pain may be a somatic flashback to the original
traumatic event, much like flashbacks in other modalities
(76). To the extent that this is the case, it may be possible to
prevent or minimize the risk of developing pain-related PTSD
flashbacks by early treatment with analgesics or other agents.
Along these lines, it has been shown that secondary preven-
tion of PTSD may be possible with propranolol (77). What
about cases wherein pain predated PTSD? We speculate that
PTSD (and, likely, its subsyndromal manifestations) leads to
increased reporting of pain and that this is influenced by vari-
ous cognitive and physiological factors.
It is also important to consider the extent to which specific
PTSD symptoms are influenced by pain. We have used the
factor analytic approach in preliminary attempts to clarify this
issue. This approach is based on the assumption that distinct
factors correspond to discrete mechanisms (that is, separate
operational processes for each symptom domain [78]). If this
is the case, then disentangling the association between symp-
toms of PTSD and (chronic) pain may help us to better under-
stand the phenomenology of each—particularly when they
co-occur. To this end, we have shown that a 4-factor intercor-
related model (that is, a PTSD model comprising 4 interre-
lated factors of reexperiencing, avoidance, numbing, and
hyperarousal) and a hierarchical 2-factor model (that is, a
PTSD model comprising 2 lower-order factors of reexperi-
encing–avoidance and numbing–hyperarousal) provided a
good fit to the PTSD-symptom data derived from groups of
United Nations peacekeepers with and without chronic pain
(75). Of particular importance here, the final models for each
group were different in several important ways: specifically,
we observed significant differences on 1 reexperiencing item
(physical reactions to reminders of trauma), 2 numbing items
(emotional numbing and sense of foreshortened future), and 1
hyperarousal item (being hypervigilant).
This suggests that chronic pain may have a cumulative nega-
tive impact upon these particular PSTD symptoms. That is,
physical reaction to reminders of the trauma, feeling emotion-
ally numb, having a sense of foreshortened future, and hyper-
vigilance may take on particular significance when pain
co-occurs with PTSD. This is not surprising when one consid-
ers (as noted above) that these symptoms are common to many
patients with chronic pain. Along these lines, it has been sug-
gested that PTSD symptoms are aggravated by stimuli and
situations that resemble some aspect of the original traumatic
event (79). It remains to be determined how specific mecha-
nisms (for example, hypervigilance or attentional bias for
threat cues and dysregulation of the endogenous opioid sys-
tem) operate in individuals with both PTSD and chronic pain,
although it seems likely that their operations are not mutually
exclusive.
Of particular relevance to future investigation in the area is the
notion that co-occurring chronic pain and PTSD are not neces-
sarily distinct disorders but, rather, intimately connected and
overlapping (29). This idea, supported by much of the empiri-
cal work reviewed above, suggests several testable postulates
of the relation between these 2 conditions. General postu-
lates—based on notions of shared vulnerability and mutual
maintenance (3)—are as follows:
1. Vulnerability factors, particularly anxiety sensitivity, have
been shown to be elevated in patients with PTSD and in
chronic pain patients classified as dysfunctional. If elevated
anxiety sensitivity is a vulnerability for both PTSD and
chronic pain, then those with this vulnerability (prospectively
measured) who experience a painful injury should be more
likely to develop PTSD. An intriguing question is whether
those who are vulnerable but experience a trauma that is not
associated with a painful injury (for example, witnessing an
accident or death) are equally likely to experience significant
and persistent pain.
2. Reminders of trauma typically trigger arousal. If pain is a
reminder of trauma, then patients with comorbid PTSD and
pain should actively avoid activities and events that trigger
acute pain sensations. This avoidance, if persistent, will have
a direct relation to functional limitations and disability. It may
also prevent activation of the fear network, which in turn will
maintain symptoms over time.
3. Attentional biases have been observed in both PTSD and
chronic pain (particularly in those who are pain-phobic). If
pain does serve as a reminder of trauma, then patients with
comorbid PTSD and pain should demonstrate attentional bias
toward both trauma-relevant cues and pain cues. There is pre-
liminary evidence from a modified Stroop paradigm suggest-
ing that this is indeed the case (80).
4. Pain threshold and tolerance are affected by elevations in
anxiety. Since anxiety is a central feature of PTSD, the experi-
ence of PTSD may reduce pain threshold and pain tolerance.
In combination with aforementioned factors, these reductions
may influence distress and disability levels. In the context of
pain threshold and tolerance, it will be interesting to test the
notion that comorbid PTSD and chronic pain overtax avail-
able coping recourses in patients with both conditions.
5. There are several other concomitants to both PTSD and
chronic pain, depression being the most common. It is possi-
ble that depression-related changes, such as fatigue and re-
duced activity levels, exacerbate and maintain both PTSD and
chronic pain symptoms, as well as associated disability. In
tests of the shared vulnerability and mutual maintenance
model, careful consideration needs to be given to depression
and other third-party factors.
General Clinical Implications
The literature reviewed above indicates that PTSD and pain
often co-occur in patients presenting for treatment of either
condition alone. As well, there is some evidence to support the
notion that there may be a shared vulnerability and that, when
symptoms do co-occur, they are mutually maintaining. As
such, it is imperative that clinicians be aware of the relation
between PTSD and pain when assessing and treating patients
for these conditions, regardless of whether this occurs in a
psychiatric or pain specialty setting. In this section, we present
general recommendations to assist in assessing and treating
patients who present with co-occurring symptoms of PTSD or
pain.
Assessment
We recommend that clinicians who conduct diagnostic as-
sessments of patients presenting with PTSD symptoms also
screen for the presence of existing pain conditions (for exam-
ple, fibromyalgia or chronic musculoskeletal pain). This can
be accomplished by including questions about the nature and
locations of a patient’s pain, about triggers of pain, about the
duration of pain, and about pain-related disability or interfer-
ence with daily activities. Some may prefer using a structured
clinical interview format (for example, the Somatoform Dis-
orders Section of the Structured Clinical Interview for DSM-
IV [SCID-I/NP] [81]) as a means of collecting this informa-
tion. However, we recommend self-report measures like the
McGill Pain Questionnaire-Short Form (82), the Multidimen-
sional Pain Inventory (83), and where appropriate, the Pain
Anxiety Symptoms Scale (84). We also recommend that pa-
tients presenting with pain complaints, particularly when
these are chronic, be assessed for the presence of PTSD symp-
toms. This can be achieved by including questions from struc-
tured clinical interviews (for example, the PTSD section of
the SCID [81] or the Clinician Administered PTSD Scale re-
vised [85]) or self- report measures (like the PTSD Symptom
Scale [86] or the Posttraumatic Stress Disorder Checklist
[87]). In these cases, full and subsyndromal PTSD may have
an impact on pain and pain-related behaviours. To facilitate
appropriate treatment, it is important to consider the presence
of co-occurring pain symptoms in those seeking treatment for
PTSD, and vice versa. However, we also recommend that lev-
els of anxiety sensitivity be assessed and considered in treat-
ment planning (see below). Anxiety sensitivity can be
efficiently assessed using the 16-item Anxiety Sensitivity In-
dex (88).
Treatment
When PTSD and pain symptoms co-occur, it is likely that cli-
nicians will be required to modify treatment protocols accord-
ingly. For example, clinicians may have to adapt existing
cognitive-behavioural therapy programs to address both
PTSD symptoms and pain management strategies. Descrip-
tions of existing treatment protocols for PTSD (11,58,89) and
chronic pain (90,91) can be found elsewhere . Within the con-
text of these protocols, it appears that incorporating treat-
ments to reduce anxiety sensitivity may improve the treatment
of PTSD (58) and chronic pain (64), or quite likely, both,
when they co-occur. Current evidence suggests that the most
potent method for reducing anxiety sensitivity is interoceptive
exposure therapy, although most studies to date have been
conducted in patients with panic disorder (56,63). Similar
considerations apply to health care providers prescribing
medication regimens, alone or in combination with psycho-
therapy, for the treatment of PTSD and chronic pain. To the
best of our knowledge, there are no systematic empirical data
to suggest whether treatment efficacy would be improved by
treating one condition or the other first, rather than addressing
them simultaneously. As noted above, pilot data from a small
randomized trial indicate that propranolol, a beta blocker of-
ten used for its analgesic properties, may be effective in the
secondary treatment of PTSD (77); thus, it may be effective in
simultaneous symptom relief. Regardless of the specific treat-
ment approach, it appears that special attention needs to be
paid to the common co-occurrence of these conditions when
discussing treatment options with patients.
Conclusions
PTSD and chronic pain are conditions that commonly co-
occur. Researchers have found that to some extent these con-
ditions share phenomenological characteristics, including
anxiety and hyperarousal, behavioural avoidance, emotional
lability, and an attentional bias toward somatic cues. Shared
vulnerability and mutual maintenance models hold promise in
improving our understanding of the relation. However, fur-
ther research is required to help delineate the relation so that
we can develop a better overall understanding of these 2 disor-
ders, together with more effective assessment and treatment
protocols for use when they co-occur. Clinically, a failure to
appreciate the intricacies of co-occurring PTSD and chronic
pain may result in reduced treatment efficacy and continuing
negative outcomes.
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